Clinical trials
Carcinoma, Hepatocellular trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
153 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2005 | 1 |
| 2006 | 3 |
| 2007 | 3 |
| 2008 | 6 |
| 2009 | 7 |
| 2010 | 5 |
| 2011 | 5 |
| 2012 | 6 |
| 2013 | 7 |
| 2014 | 4 |
| 2015 | 7 |
| 2016 | 7 |
| 2017 | 12 |
| 2018 | 12 |
| 2019 | 11 |
| 2020 | 6 |
| 2021 | 15 |
| 2022 | 10 |
| 2023 | 14 |
| 2024 | 2 |
| 2025 | 7 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 85 |
| Active, not recruiting | 23 |
| Recruiting | 18 |
| Terminated | 17 |
| Unknown status | 7 |
| Withdrawn | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bayer | 12 |
| Bristol-Myers Squibb | 9 |
| Hoffmann-La Roche | 9 |
| AbbVie | 7 |
| AstraZeneca | 6 |
| Eli Lilly and Company | 6 |
| Clinica Universidad de Navarra, Universidad de Navarra | 5 |
| Eisai Inc. | 4 |
| Exelixis | 4 |
| Merck Sharp & Dohme LLC | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Hepatocellular | 153 |
| Liver Neoplasms | 26 |
| Neoplasms | 21 |
| Carcinoma, Non-Small-Cell Lung | 19 |
| Colorectal Neoplasms | 15 |
| Squamous Cell Carcinoma of Head and Neck | 14 |
| Triple Negative Breast Neoplasms | 13 |
| Carcinoma, Renal Cell | 12 |
| Melanoma | 12 |
| Stomach Neoplasms | 11 |
Trials
Showing 51 to 75 of 153. Each trial links to its page on Pharma Observatory.
53 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.